Logo image of CAMT

CAMTEK LTD (CAMT) Stock Fundamental Analysis

USA - NASDAQ:CAMT - IL0010952641 - Common Stock

121.03 USD
+2.06 (+1.73%)
Last: 10/14/2025, 8:00:02 PM
121.21 USD
+0.18 (+0.15%)
Pre-Market: 10/15/2025, 5:02:00 AM
Fundamental Rating

6

Overall CAMT gets a fundamental rating of 6 out of 10. We evaluated CAMT against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. CAMT scores excellent on profitability, but there are some minor concerns on its financial health. CAMT shows excellent growth, but is valued quite expensive already. These ratings would make CAMT suitable for growth investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CAMT had positive earnings in the past year.
Each year in the past 5 years CAMT has been profitable.
In the past 5 years CAMT always reported a positive cash flow from operatings.
CAMT Yearly Net Income VS EBIT VS OCF VS FCFCAMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

CAMT has a better Return On Assets (13.72%) than 85.71% of its industry peers.
CAMT has a Return On Equity of 21.36%. This is amongst the best in the industry. CAMT outperforms 86.61% of its industry peers.
CAMT has a better Return On Invested Capital (13.47%) than 86.61% of its industry peers.
CAMT had an Average Return On Invested Capital over the past 3 years of 11.43%. This is in line with the industry average of 10.94%.
The last Return On Invested Capital (13.47%) for CAMT is above the 3 year average (11.43%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.72%
ROE 21.36%
ROIC 13.47%
ROA(3y)11.71%
ROA(5y)10.6%
ROE(3y)19.67%
ROE(5y)17.82%
ROIC(3y)11.43%
ROIC(5y)11.2%
CAMT Yearly ROA, ROE, ROICCAMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

With an excellent Profit Margin value of 28.38%, CAMT belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
CAMT's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 26.86%, CAMT belongs to the top of the industry, outperforming 86.61% of the companies in the same industry.
In the last couple of years the Operating Margin of CAMT has grown nicely.
With a decent Gross Margin value of 50.46%, CAMT is doing good in the industry, outperforming 63.39% of the companies in the same industry.
CAMT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.86%
PM (TTM) 28.38%
GM 50.46%
OM growth 3Y-0.13%
OM growth 5Y9.82%
PM growth 3Y7.46%
PM growth 5Y11.08%
GM growth 3Y-0.69%
GM growth 5Y0.63%
CAMT Yearly Profit, Operating, Gross MarginsCAMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

CAMT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CAMT has more shares outstanding
The number of shares outstanding for CAMT has been increased compared to 5 years ago.
The debt/assets ratio for CAMT has been reduced compared to a year ago.
CAMT Yearly Shares OutstandingCAMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CAMT Yearly Total Debt VS Total AssetsCAMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 11.73 indicates that CAMT is not in any danger for bankruptcy at the moment.
CAMT has a better Altman-Z score (11.73) than 75.89% of its industry peers.
CAMT has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
CAMT has a worse Debt to Equity ratio (0.32) than 61.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 11.73
ROIC/WACC1.17
WACC11.56%
CAMT Yearly LT Debt VS Equity VS FCFCAMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 5.41 indicates that CAMT has no problem at all paying its short term obligations.
CAMT's Current ratio of 5.41 is fine compared to the rest of the industry. CAMT outperforms 75.89% of its industry peers.
CAMT has a Quick Ratio of 4.38. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
CAMT has a better Quick ratio (4.38) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 5.41
Quick Ratio 4.38
CAMT Yearly Current Assets VS Current LiabilitesCAMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.80% over the past year.
CAMT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 34.86% yearly.
Looking at the last year, CAMT shows a very strong growth in Revenue. The Revenue has grown by 27.82%.
CAMT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.20% yearly.
EPS 1Y (TTM)30.8%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%19.7%
Revenue 1Y (TTM)27.82%
Revenue growth 3Y16.74%
Revenue growth 5Y26.2%
Sales Q2Q%20.2%

3.2 Future

CAMT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.41% yearly.
CAMT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.97% yearly.
EPS Next Y15.5%
EPS Next 2Y12.36%
EPS Next 3Y12.44%
EPS Next 5Y16.41%
Revenue Next Year15.52%
Revenue Next 2Y11.88%
Revenue Next 3Y11.79%
Revenue Next 5Y15.97%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CAMT Yearly Revenue VS EstimatesCAMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M
CAMT Yearly EPS VS EstimatesCAMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 39.04, the valuation of CAMT can be described as expensive.
Based on the Price/Earnings ratio, CAMT is valued a bit cheaper than the industry average as 63.39% of the companies are valued more expensively.
CAMT's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.50.
The Price/Forward Earnings ratio is 34.12, which means the current valuation is very expensive for CAMT.
CAMT's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of CAMT to the average of the S&P500 Index (22.99), we can say CAMT is valued slightly more expensively.
Industry RankSector Rank
PE 39.04
Fwd PE 34.12
CAMT Price Earnings VS Forward Price EarningsCAMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

CAMT's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 41.64
CAMT Per share dataCAMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of CAMT may justify a higher PE ratio.
CAMT's earnings are expected to grow with 12.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.52
PEG (5Y)1.12
EPS Next 2Y12.36%
EPS Next 3Y12.44%

0

5. Dividend

5.1 Amount

No dividends for CAMT!.
Industry RankSector Rank
Dividend Yield N/A

CAMTEK LTD

NASDAQ:CAMT (10/14/2025, 8:00:02 PM)

Premarket: 121.21 +0.18 (+0.15%)

121.03

+2.06 (+1.73%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-10 2025-11-10/bmo
Inst Owners52.66%
Inst Owner Change0%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap5.53B
Analysts82.5
Price Target101.08 (-16.48%)
Short Float %15.9%
Short Ratio9.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.33
Dividend Growth(5Y)56.87%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.87%
Min EPS beat(2)-2.25%
Max EPS beat(2)0.51%
EPS beat(4)3
Avg EPS beat(4)1.36%
Min EPS beat(4)-2.25%
Max EPS beat(4)6.06%
EPS beat(8)7
Avg EPS beat(8)2.75%
EPS beat(12)10
Avg EPS beat(12)2.39%
EPS beat(16)12
Avg EPS beat(16)2.23%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-2.27%
Max Revenue beat(2)-0.59%
Revenue beat(4)1
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.3%
Revenue beat(12)2
Avg Revenue beat(12)-0.68%
Revenue beat(16)3
Avg Revenue beat(16)-0.74%
PT rev (1m)0%
PT rev (3m)16.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.74%
EPS NY rev (1m)-0.11%
EPS NY rev (3m)-0.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.9%
Valuation
Industry RankSector Rank
PE 39.04
Fwd PE 34.12
P/S 11.73
P/FCF N/A
P/OCF N/A
P/B 8.82
P/tB 10.22
EV/EBITDA 41.64
EPS(TTM)3.1
EY2.56%
EPS(NY)3.55
Fwd EY2.93%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.31
BVpS13.72
TBVpS11.84
PEG (NY)2.52
PEG (5Y)1.12
Profitability
Industry RankSector Rank
ROA 13.72%
ROE 21.36%
ROCE 14.98%
ROIC 13.47%
ROICexc 13.47%
ROICexgc 14.99%
OM 26.86%
PM (TTM) 28.38%
GM 50.46%
FCFM N/A
ROA(3y)11.71%
ROA(5y)10.6%
ROE(3y)19.67%
ROE(5y)17.82%
ROIC(3y)11.43%
ROIC(5y)11.2%
ROICexc(3y)23.25%
ROICexc(5y)34.93%
ROICexgc(3y)26.06%
ROICexgc(5y)36.79%
ROCE(3y)12.71%
ROCE(5y)12.46%
ROICexcg growth 3Y-39.43%
ROICexcg growth 5Y-18.22%
ROICexc growth 3Y-41.68%
ROICexc growth 5Y-20%
OM growth 3Y-0.13%
OM growth 5Y9.82%
PM growth 3Y7.46%
PM growth 5Y11.08%
GM growth 3Y-0.69%
GM growth 5Y0.63%
F-ScoreN/A
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA 1.44
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.41
Quick Ratio 4.38
Altman-Z 11.73
F-ScoreN/A
WACC11.56%
ROIC/WACC1.17
Cap/Depr(3y)145.49%
Cap/Depr(5y)140.52%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.15%
Profit Quality(3y)82.13%
Profit Quality(5y)89.36%
High Growth Momentum
Growth
EPS 1Y (TTM)30.8%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%19.7%
EPS Next Y15.5%
EPS Next 2Y12.36%
EPS Next 3Y12.44%
EPS Next 5Y16.41%
Revenue 1Y (TTM)27.82%
Revenue growth 3Y16.74%
Revenue growth 5Y26.2%
Sales Q2Q%20.2%
Revenue Next Year15.52%
Revenue Next 2Y11.88%
Revenue Next 3Y11.79%
Revenue Next 5Y15.97%
EBIT growth 1Y48.56%
EBIT growth 3Y16.58%
EBIT growth 5Y38.59%
EBIT Next Year22.48%
EBIT Next 3Y18.1%
EBIT Next 5Y19.53%
FCF growth 1Y57.63%
FCF growth 3Y25.41%
FCF growth 5Y36.93%
OCF growth 1Y53.8%
OCF growth 3Y26.02%
OCF growth 5Y37.72%